M

Maze Therapeutics

Clinical-stage biotech developing precision kidney therapies

Senior Research Associate 1 – Compound Management

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • A minimum Bachelor of Science degree in Biological or Chemical Sciences and at least 3 years of experience in small-molecule compound handling and processing.
  • Experience with laboratory automation, specifically liquid-handling platforms such as Tecan EVO, Labcyte ECHO, or similar systems.
  • Experience troubleshooting and maintaining instrumentation platforms and automated integrated systems.
  • Strong attention to detail and organizational skills, with the ability to multitask across initiatives under tight deadlines.
  • Effective communication and interpersonal skills for cross-functional collaboration and teamwork.

Responsibilities

  • Manage the weighing, storage, maintenance, and distribution of compound inventories.
  • Operate automated laboratory equipment to support sample processing.
  • Monitor the compound request queue and fulfill requests in a timely manner.
  • Partner with the Facilities Department to ship and track compounds locally and internationally to collaborating contract research organizations.
  • Perform routine sample quality-control checks and analysis.
  • Coordinate with research and development operations, vendors, and contract research organizations to procure, track, and process samples for internal and external studies.
  • Assist in developing and implementing workflows for accurate high-throughput compound processing.
  • Coordinate routine or ad hoc compound plating across departments.
  • Maintain laboratory consumables inventory.

Desired Qualifications

  • Knowledge and use of Mosaic for optimizing compound-processing workflows.

About the Company

Maze Therapeutics

Clinical-stage biotech developing precision kidney therapies

Maze Therapeutics is a clinical-stage biotechnology company that builds precision medicines for diseases with large unmet needs by using human genetics to copy protective genetic variants into small-molecule drugs. Its Compass platform maps genetic insights to therapeutic targets through variant functionalization, guiding drug discovery across research, preclinical, and clinical stages. Its lead program MZE829 targets APOL1-driven kidney disease, while MZE782 is in development for chronic kidney disease and phenylketonuria. Unlike many peers, Maze focuses on turning natural genetic protections into medicines and aims to develop and commercialize its own therapies.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Maze Therapeutics

See more jobs